Key result
The prevalence of Joint Hypermobility Syndrome was 39.1% in the pain management clinic and 37.0% in the general rheumatology clinic, compared to 10.9% in the orthopaedic clinic.
Cross-Sectional (n=138)
No
Absolute Event Rate: 39.1% vs 10.9%
Joint Hypermobility Syndrome is highly prevalent in pain management and rheumatology clinics compared to orthopaedic clinics, highlighting the need for accurate diagnostic criteria and appropriate referral pathways.
Clinic-specific prevalence patterns may inform referral considerations; leaves open validation of diagnostic criteria in prospective studies.
Aim: Joint Hypermobility Syndrome (JHS) is an inherited disorder of the connective tissue and can lead to widespread pain, joint instability and fatigue. In order to understand where patients with musculoskeletal symptoms and JHS present to in secondary care we have established the prevalence of JHS within the pain management service, a general rheumatology clinic and an orthopaedic clinic of a single general hospital. Method: A total of 138 patients attending the pain management service, a general rheumatology clinic and an orthopaedic clinic were surveyed for Joint Hypermobility Syndrome as part of their usual care using the Brighton criteria. Results: The pain management and general rheumatology clinics both demonstrated a similar prevalence of 39.1% and 37.0% respectively. The orthopaedic clinic demonstrated a much lower prevalence of 10.9%. Conclusion: There were a higher number of people with JHS presenting to the pain management and general rheumatology clinics than the orthopaedic clinic. This reflects an appropriate pathway for this multiple joint pathology. The difficulty in classifying people with JHS is discussed as these figures may reflect an over classification of the condition.
No takes yet. Share an insight, caveat, or question.
To et al. (2016) conducted a cross-sectional in Joint Hypermobility Syndrome (n=138). Attending pain management or general rheumatology clinics vs. Attending orthopaedic clinic was evaluated on Prevalence of Joint Hypermobility Syndrome using the Brighton criteria. The prevalence of Joint Hypermobility Syndrome was 39.1% in the pain management clinic and 37.0% in the general rheumatology clinic, compared to 10.9% in the orthopaedic clinic.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: